VTVT logo

VTVT
vTv Therapeutics Inc - Ordinary Shares - Class A

14,695
Mkt Cap
$134.75M
Volume
26,238.00
52W High
$44.00
52W Low
$14.00
PE Ratio
-9.63
VTVT Fundamentals
Price
$32.24
Prev Close
$31.27
Open
$31.41
50D MA
$36.59
Beta
0.90
Avg. Volume
68,209.18
EPS (Annual)
-$3.20
P/B
1.97
Rev/Employee
$0.00
$247.93
Loading...
Loading...
News
all
press releases
vTv Therapeutics Inc. (NASDAQ:VTVT) Short Interest Update
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 112,740 shares, a...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
vTv Therapeutics (NASDAQ:VTVT) Stock Passes Below Fifty Day Moving Average - Time to Sell?
vTv Therapeutics (NASDAQ:VTVT) Stock Price Crosses Below 50-Day Moving Average - Should You Sell...
MarketBeat·7d ago
News Placeholder
Wall Street Analysts See a 39.9% Upside in vTv Therapeutics (VTVT): Can the Stock Really Move This High?
The mean of analysts' price targets for vTv Therapeutics (VTVT) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·11d ago
News Placeholder
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Grows By 24.6%
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 82,236 shares, a growth of 24.6% from the March 15th total of 65,987 shares. Based on an average daily...
MarketBeat·15d ago
News Placeholder
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat reports. One...
MarketBeat·16d ago
News Placeholder
Wall Street Analysts Think vTv Therapeutics (VTVT) Could Surge 31.58%: Read This Before Placing a Bet
The mean of analysts' price targets for vTv Therapeutics (VTVT) points to a 31.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·29d ago
News Placeholder
vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts
vTv Therapeutics Inc. (NASDAQ:VTVT - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six brokerages that are currently covering the firm, MarketBeat Ratings...
MarketBeat·1mo ago
News Placeholder
Wall Street Analysts Believe vTv Therapeutics (VTVT) Could Rally 39.86%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 39.9% in vTv Therapeutics (VTVT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks·1mo ago
News Placeholder
Baker BROS. Advisors LP Has $3.46 Million Holdings in vTv Therapeutics Inc. $VTVT
Baker BROS. Advisors LP increased its stake in shares of vTv Therapeutics Inc. (NASDAQ:VTVT - Free Report) by 52.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·2mo ago
News Placeholder
Wall Street Zen Upgrades vTv Therapeutics (NASDAQ:VTVT) to "Hold"
Wall Street Zen upgraded shares of vTv Therapeutics from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest VTVT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.